Gülzer DELİKTAŞ, Rahime KADA DÜKEN, Hacer UYANIKOĞLU
Acta Medica Ruha - 2026;4(2):62-72
Objective: To compare the maturation rates of oocytes collected in patients with low, normal, and high ovarian reserve according to the anti-mullerian hormone (AMH) level and antral follicule count (AFC), where in-vitro fertizition (IVF) was performed in the in-vitro fertilization clinic of our faculty of medicine between 2017-2022. Methods: This retrospective study included women aged between 23 and 45 who underwent IVF treatment between 2017 and 2022. Patients were divided to three groups. Group 1: low; group 2: normal; group 3: high ovarian reserve, according to the ovarian reserve. Age, AFC, AMH values, body mass index, oocyte maturation rate, total oocyte counts, FSH, LH, TSH and estradiol levels were recorded. Results: 22% of the patients had low, 46.1% normal, and 31.9% had high ovarian reserve. There was a statistically significant difference among the groups according to the age, FSH, LH and E2 levels, drug dose used, number of oocytes collected (COC) and number of MII oocytes (p<0.001). Ovitrelle was used in 81.6% of the participants, Gonapeptly in 17.8% and Ovitrelle+Gonapeptly in 0.6% of the participants, for oocyte maturation. The mean total MII oocyte count were higher in the gonapeptly used group. It was observed that 67.3% of MII oocyte in group 1 women, 66.9% of MII oocyte in group 2 women, and 67.3% of MII oocyte in group 3 women. There was a similar oocyte maturation rate among the groups. Conclusion: There was a relationship between ovarian reserve and COC, but maturation rates were similar among the groups. This suggests that MII oocytes can be obtained with individualized treatments, regardless of ovarian reserve.
